Quarterly Updates12 Nov 2025, 05:32 pm
Supriya Lifescience Ltd Reports Q2 and H1 Results for FY2025-26
AI Summary
Supriya Lifescience Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company's revenue from operations stands at INR 1,998.33 million for Q2 and INR 3,449.07 million for H1. The total income for Q2 is INR 1,477.48 million and INR 3,503.06 million for H1. The net profit for Q2 is INR 120.04 million and INR 212.58 million for H1. The earnings per equity share for Q2 is INR 6.27 and INR 12.54 for H1.
Key Highlights
- Revenue from operations for Q2 is INR 1,998.33 million and INR 3,449.07 million for H1.
- Total income for Q2 is INR 1,477.48 million and INR 3,503.06 million for H1.
- Net profit for Q2 is INR 120.04 million and INR 212.58 million for H1.
- Earnings per equity share for Q2 is INR 6.27 and INR 12.54 for H1.